fashion -WSS

fashion

author：comprehensive 2025-10-02 21:05:50 - browse：94

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

WSS

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

'The Exorcist' director William Friedkin dead at 87

FTC falls short on scrutinizing hospital mergers, study says

Why rehabilitation engineers need to center patients in their research

Cell therapy fails to slow type 1 diabetes, but safety is established

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Peter Hotez and the public health issue of online harassment

Why workplace violence is so common in health care

Dobbs anniversary: the lost opportunity of abortion as health care

At least 12 people were injured in a blast at a port in northwest Turkey

Sports medicine is finally prioritizing gender equality

Why workplace violence is so common in health care

Anesthesiologist group: stop taking Ozempic before surgery

At least 12 people were injured in a blast at a port in northwest Turkey

The cancer drug shortage isn’t new — and neither are the solutions

Cell therapy fails to slow type 1 diabetes, but safety is established

hotspot

Close Medicare's dangerous gaps in addiction treatment coverage

Democratic lawmaker calls for 'well

Getting Alzheimer's drug Leqembi to patients can be a challenge

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Bird flu in milk supply is likely coming from asymptomatic cows

Moderna hits safety problems in bold bid to reinvent medicine

knowledge

Wikipedia

hotspot

knowledge